Cargando…
Genome-wide gene expression analysis for target genes to differentiate patients with intestinal tuberculosis and Crohn’s disease and discriminative value of FOXP3 mRNA expression
Background and aims: Crohn’s disease (CD) and intestinal tuberculosis (ITB) are both chronic granulomatous conditions with similar phenotypic presentations. Hence, there is need for a biomarker to differentiate between both these two diseases. This study aimed at genome-wide gene expression analysis...
Autores principales: | Ahuja, Vineet, Subodh, Swati, Tuteja, Amit, Mishra, Veena, Garg, Sushil Kumar, Gupta, Neha, Makharia, Govind, Acharya, SK |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4760064/ https://www.ncbi.nlm.nih.gov/pubmed/25969456 http://dx.doi.org/10.1093/gastro/gov015 |
Ejemplares similares
-
CD4(+) CD25(+) FOXP3(+) T cell frequency in the peripheral blood is a biomarker that distinguishes intestinal tuberculosis from Crohn’s disease
por: Tiwari, Veena, et al.
Publicado: (2018) -
Prospective validation of CD4(+) CD25(+) FOXP3(+) T-regulatory cells as an immunological marker to differentiate intestinal tuberculosis from Crohn’s disease
por: Rampal, Ritika, et al.
Publicado: (2021) -
VSL#3 induces and maintains short-term clinical response in patients with active microscopic colitis: a two-phase randomised clinical trial
por: Rohatgi, Sarika, et al.
Publicado: (2015) -
Proteome analysis of the macroscopically affected colonic mucosa of Crohn’s disease and intestinal tuberculosis
por: Rukmangadachar, Lokesh A., et al.
Publicado: (2016) -
Differentiating Crohn’s disease from intestinal tuberculosis
por: Kedia, Saurabh, et al.
Publicado: (2019)